Pediatr. praxi. 2024;25(3):176-179 | DOI: 10.36290/ped.2024.036

Incidentally detected abdominal mass - atypical origin, atypical diagnosis

MUDr. Terézia Tureková1, 3, MUDr. Jan Máchal, Ph.D.2, 3, MUDr. Pavel Mazánek2, 3
1 Klinika dětské onkologie, Fakultní nemocnice, Brno
2 Oddělení dětské hematologie a biochemie, Fakultní nemocnice, Brno
3 Lékařská fakulta, Masarykova univerzita, Brno

The differential diagnosis of a pathological abdominal mass is broad. Usually, the first thing the attending physician is concerned of is a malignant disease. Neuroblastomas, hepatoblastomas, lymphomas, sarcomas, Wilms' or ovarian tumors can be palpated in the abdominal cavity. As part of the proper differential diagnostic process, it is also nece­ssary to keep in mind non-malignant causes that may point to other serious diseases. This case report presents the patient with accidentally palpated abdominal resistance, who was in diagnostic process for suspected malignancy. In this patient, the mass did not have a malignant origin, it was a large hematoma, which was the first symptom of previously unrecognized severe hemophilia A. Hemophilia is a rare congenital bleeding disorder that accompanies the patient and his family throughout their life. In almost one third of patients, this is a sporadic occurrence of the disease, and therefore a neonatologist or a pediatrician may encounter it in their praxis. In context of the possible serious complications that this disease brings, it is the task of the attending pediatrician to recognize the disease in time and transfer the patients to the specialist care.

Keywords: abdominal mass, congenital coagulopathies, hemophilia A, pediatrics.

Accepted: June 12, 2024; Published: June 14, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tureková T, Máchal J, Mazánek P. Incidentally detected abdominal mass - atypical origin, atypical diagnosis. Pediatr. praxi. 2024;25(3):176-179. doi: 10.36290/ped.2024.036.
Download citation

References

  1. NCCR Registries. Lymphoid Leukemias Trends in Age-Adjusted Incidence Rates, 1999-2020 [Internet]. [cit 21. leden 2024]. Available at: https://nccrexplorer.ccdi.cancer.gov/application.html.
  2. Blanchette VS, Key NS, Ljung LR, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 01. listopad 2014;12(11):1935-1939. Go to original source... Go to PubMed...
  3. Iorio A, Stonebraker JS, Chambost H, et al. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries. Ann Intern Med. 15. říjen 2019;171(8):540-546. Go to original source... Go to PubMed...
  4. Gomez K, Bolton-Maggs P. Factor XI deficiency. Haemophilia. 2008;14(6):1183-1189. Go to original source... Go to PubMed...
  5. Chalmers EA, Alamelu J, Collins PW, et al. Intracranial hae­morrhage in children with inherited bleeding disorders in the UK 2003-2015: A national cohort study. Haemoph Off J World Fed Hemoph. červenec 2018;24(4):641-647. Go to original source... Go to PubMed...
  6. Schröder A, Farhat WA, Chiasson D, et al. Serious and Fatal Complications after Neonatal Circumcision. Eur Urol Focus. září 2022;8(5):1560-1563. Go to original source... Go to PubMed...
  7. Du P, Bergamasco A, Moride Y, et al. Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review. J Blood Med. 2023;14:189-208. Go to original source... Go to PubMed...
  8. Menegatti M, Biguzzi E, Peyvandi F. Management of rare acquired bleeding disorders. Hematology. 2019;2019(1):80-87. Go to original source... Go to PubMed...
  9. Berntorp E, Fischer K, Hart DP, et al. Haemophilia. Nat Rev Dis Primer. 2021;7(1):1-19. Go to original source... Go to PubMed...
  10. O'Mahony B, Dunn AL, Leavitt AD, et al. Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1. J Thromb Haemost JTH. 2023;21(12):3450-3462. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.